Revance Therapeutics Inc - ESG Rating & Company Profile powered by AI
The ESG score includes 17 UN SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'. Check the end of this webpage for potential risks for Revance Therapeutics Inc based on sector, geography and marketcap. Alternative companies in the rating industry group for Revance Therapeutics Inc are shown.
Revance Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 1.3, social score of 3.4 and governance score of 6.7.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1089 | Zymeworks Inc | 3.9 | Medium |
| 1089 | bluebird bio Inc | 3.9 | Medium |
| 1112 | Revance Therapeutics Inc | 3.8 | Medium |
| 1112 | AcelRx Pharmaceuticals Inc | 3.8 | Medium |
| 1112 | Arcus Biosciences Inc | 3.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Revance Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Revance Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Revance Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Revance Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Revance Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Revance Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Revance Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Revance Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Revance Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Revance Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Revance Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Revance Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Revance Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Revance Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Revance Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Revance Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Revance Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Revance Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DAXI in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. for the development and regulatory approval of a biosimilar to BOTOX. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Newark, California.